Brief: Paion Gets Positive CHMP Opinion Recommending Approval Of Byfavo(R) In Procedural Sedation
Jan 29 (Reuters) - PAION AG PA8G.DE :
* PAION RECEIVES POSITIVE CHMP OPINION RECOMMENDING
APPROVAL OF BYFAVO(R) (REMIMAZOLAM) IN PROCEDURAL SEDATION
* FINAL DECISION ON MAA EXPECTED IN FIRST HALF OF 2021
* POSITIVE CHMP OPINION BASED ON DATA FROM A COMPREHENSIVE
CLINICAL PROGRAM IN PROCEDURAL SEDATION IN ADULT PATIENTS
UNDERGOING BRONCHOSCOPY OR COLONOSCOPY
Source text for Eikon: ID:nEQ42rPjMa
Further company coverage: PA8G.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on PAION AG
See all newsBrief: Paion AG To Issue Approx 4.8 Mln Shares In Capital Increase With Subscription Rights
Brief: Paion AG Reports Developments On Commercial Activities In Europe
Brief: Paion Q1 EBITDA Up At EUR 15 Mln
Brief: Paion Grants Exclusive License To Cristália For Development And Commercialization Of Remimazolam In Latin America
Brief: Paion Announces Sebastian Werner As New CFO, Effective 1 June 2022